| Income Statement |
| Total Revenue | 3.40B |
|
| Revenues (USD) | 500.94M |
| Cost of Revenue | 732.91M |
| Gross Profit | 2.67B |
| Operating Expenses | 2.14B |
| Research and Development Expense | 118.93M |
| Selling, General and Administrative Expense | 587.20M |
| Operating Income | 529.25M |
| Interest Expense | 20.02M |
| Income Tax Expense | 116.36M |
| Net Income | 441.55M |
| Net Income Common Stock | 441.55M |
| Net Income Common Stock (USD) | 65.00M |
| Consolidated Income | 426.77M |
| Net Income to Non-Controlling Interests | -14.78M |
| Earnings per Basic Share | 1.85 |
| Earnings per Basic Share (USD) | 0.27 |
| Earnings per Diluted Share | 1.80 |
| Dividends per Basic Common Share | 0.59 |
| Earning Before Interest & Taxes (EBIT) | 577.93M |
| Earning Before Interest & Taxes (USD) | 85.07M |
| Weighted Average Shares | 1.18B |
| Weighted Average Shares Diluted | 1.25B |
| Balance Sheet |
| Cash and Equivalents | 4.89B |
| Cash and Equivalents (USD) | 719.93M |
| Investments | 10.92B |
| Trade and Non-Trade Receivables | 4.32B |
| Property, Plant & Equipment Net | 665.70M |
| Total Assets | 26.07B |
| Total Debt | 1.57B |
| Total Liabilities | 9.33B |
| Accumulated Retained Earnings (Deficit) | 12.40B |
| Accumulated Other Comprehensive Income | 32.87M |
| Shareholders Equity | 16.63B |
| Shareholders Equity (USD) | 2.45B |
| Total Debt (USD) | 231.76M |
| Deferred Revenue | 1.26B |
| Goodwill and Intangible Assets | 286.24M |
| Trade and Non-Trade Payables | 739.58M |
| Tax Assets | 3.50B |
| Tax Liabilities | 1.21B |
| Cash Flow |
| Net Cash Flow from Financing | -708.06M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.66B |
| Net Cash Flow from Investing | -515.47M |
| Net Cash Flow from Operations | -389.98M |
| Effect of Exchange Rate Changes on Cash | -46.22M |